“What stage of type 1 diabetes do you have?”
That question could become a common one soon, if some leading diabetes experts succeed in establishing an official three-tiered delineation of the early stages of T1D in order to pursue research and treatments in preventing the autoimmune condition.
In other words, the kind of multi-stage disease model that exists for a handful of other conditions like Alzeimer’s, cancer, kidney disease and beyond could soon be coming to the type 1 diabetes world. A precise set of definitions is being proposed for three early stages of T1D, aimed at putting specific labels to those who don’t yet have type 1 but could be predisposed and at higher risk for eventually developing the autoimmune condition.
And no, we’re not just talking “pre-diabetes” here. This goes way beyond that, into an actual scientific definition and screening process rather than the vague abyss drawing in millions of souls who may someday develop type 2 diabetes.
Yesterday, we published an interview with a diabetes endo-researcher who’s pursuing insulin independence for those of us already living with type 1. Today, we’re looking at another side of that research coin.
“Currently, you either have T1D or don’t, but that does not fully capture the complexity of T1D for all people,” said JDRF’s Chief Scientific Officer Dick Insel at an October workshop in Bethesda, MD, that brought a handful of researchers and industry experts together to discuss this issue.